XM does not provide services to residents of the United States of America.
C
C

Clariant

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Heubach Colorants India gains after Quant Mutual Fund buys shares

BUZZ-Heubach Colorants India gains after Quant Mutual Fund buys shares ** Shares of Heubach Colorants India HEUB.NS rise as much as 19% to 558 rupees, highest since Feb. 12 ** Quant Mutual Fund bought 120,000 Heubach shares via bulk deals on Thursday, as per NSE data ** Purchases were at an avg price of 453.6 rupees, a 16% premium to Wednesday's close of 390.9 rupees ** Tradig vol on the day surges to 21x the 30-day avg ** Stock up 35% so far this week, eyes best weekly gain since Feb.
C

Asmi, Beiersdorf, SSE

EUROPE RESEARCH ROUNDUP-Asmi, Beiersdorf, SSE June 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Asmi, Beiersdorf and SSE, on Friday. HIGHLIGHTS * Arcadis NV ARDS.AS : KBC Securities raises to accumulate from buy * Asmi ASMI.AS : Berenberg raises target price to EUR 720 from EUR 640 * Beiersdorf BEIG.DE : HSBC raises target price to EUR 158 from EUR 152 * Nibe Industrier AB NIBEB.ST : HSBC cuts to hold from buy * SSE SSE.L : HS
A
B
B
C
D
E
E
I
J
L
L
S
W

Asmi, Beiersdorf, SSE

CORRECTED-EUROPE RESEARCH ROUNDUP-Asmi, Beiersdorf, SSE Corrects Greenyard NV entry to say KBC Securities raises target price to EUR 9.5 from EUR 8.5 (not 6.30) and Arcadis NV entry to say KBC Securities cuts (not raises) to 'accumulate' from 'buy'; raises target price to EUR 66 from EUR 61 (not 61.7 June 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Asmi, Beiersdorf and SSE, on Friday.
A
B
B
B
C
D
D
E
E
I
J
K
L
L
P
R
S
V
V
V
W
P
S

Swiss stocks - Factors to watch on May 31

Swiss stocks - Factors to watch on May 31 May 31 - Here are some of the main factors that may affect Swiss stocks on Friday: NOVARTIS AG NOVN.S Novartis sues Maryland over law mandating discounts for hospitals' outside pharmacies ( Full story ) The company also says phase III data confirm sustained efficacy and long-term safety Of oral remibrutinib in chronic spontaneous urticaria ( Full story ) COMPANY STATEMENTS Meyer Burger Technology AG MBTN.S - Board Of Directors Proposes Reverse Share Spli
C
N
U

Swiss stocks - Factors to watch on May 30

Swiss stocks - Factors to watch on May 30 ZURICH/GDANSK, May 30(Reuters) - Here are some of the main factors that may affect Swiss stocks on Thursday: UBS UBSG.S Swiss bank UBS said on Thursday it was making changes to its executive board. ( Full Story ) EX-DIVIDEND CLARIANT CLN.S - 0.42 CHF/shr dividend ECONOMY Swiss trade data for April due at 0600 GMT.
C
U
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.